Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

IMA new masthead1

November 15, 2014

View Archives Issues

  • Who Is Shopping for You?

    In a study of young adults, attempted physician deception to obtain a pharmaceutical drug was found to exist in a limited manner along with general characteristics of those patients who may divert medications.
  • Medical Treatment Is Effective, ­But Only if It is Used

    In this randomized controlled trial, those sleep apnea patients who received a brief (< 1 hour, total) motivational education program had substantially better continuous positive airway pressure adherence in a short-term follow-up.
  • Ledipasvir and Sofosbuvir Tablets (Harvoni ® )

    The first fixed-dose combination drug product has been approved for the treatment of chronic hepatitis C virus (HCV) genotype 1 infection. The combination contains a previously approved HCV nucleotide analog NS5B polymerase inhibitor, sofosbuvir (SOF), and a NS5A inhibitor, ledipasvir (LDV). This represents the first treatment option for HCV genotype 1 that does not require ribavirin or interferon.
  • Insulin Pump Outperforms Multiple Injections in Type 2 Diabetes

    Sometimes despite best efforts on the part of the clinician and the type 2 diabetes patient, A1c goals are not met. Although in some circumstances the underlying limitation to goal attainment is readily discernible (hypoglycemic episodes, non-compliance, medication misadministration, excessive weight gain, other adverse effects), it is not always so clear.
  • Chest Pain and an Anterior ‘Culprit’

    The ECG in the Figure was obtained from a patient with new-onset chest pain. What is the likely culprit artery? Is this patient a good candidate for acute reperfusion?